Article
Implementation of a cost-effective unlabeled probe high-resolution melt assay for genotyping of Factor V Leiden.
Genetic testing and molecular biomarkers - 1 Apr 2011
Svensson Annika M, Chou Lan-Szu, Meadows Cindy, Miller Christine E, Palais Robert, Sumner Kelli, Wayman Tyler C, Mao Rong, Lyon Elaine
Abstract excerpt
The Factor V Leiden mutation (FVL; c.1601G>A, p.Arg534Gln), the most common aberration underlying activated Protein C resistance, results in disruption of a major anticoagulation pathway and is a leading cause of inherited thrombophilia. A high-throughput assay for FVL mutation detection was deve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
